Sequential Use of Efgartigimod and Romiplostim Restored Platelet Response in Two Multi-Refractory Thrombocytopenic Patients, Previously Treated with Thrombopoietin Receptor Agonists
Mediterr J Hematol Infect Dis
.
2023 Mar 1;15(1):e2023021.
doi: 10.4084/MJHID.2023.021.
eCollection 2023.
Authors
Monica Carpenedo
1
2
,
Arianna Zappaterra
1
,
Beatrice Ferrari
1
,
Giulia Cotilli
1
Affiliations
1
A.O San Gerardo di Monza e Università di Milano Bicocca, Hematology and Transplant Unit. via Pergolesi 33 Monza, 20900, Italy.
2
ASST Fatebenefratelli-Sacco, Ospedale L. Sacco, Polo Didattico Università degli Studi di Milano, Via G.B Grassi 74, Milan, 20154, Italy.
PMID:
36908865
PMCID:
PMC10000878
DOI:
10.4084/MJHID.2023.021
No abstract available
Keywords:
Chronic ITP; ITP; New agents; New drugs; Refractory ITP; Thrombopoietin.